| Name |
Other |
| AFP-L3 |
Detects AFP-L3 presence |
| Alpha Catenin |
|
| APC |
|
| BAT-26 |
|
| Bladder cancer test |
Gene expression profiling in blood cells |
| BladderChek |
Urine test for protein NMP22 |
| Breast Cancer Detection |
|
| Breast Cancer Outcome Prediction Test |
DNA methylation markers that correlate closely with prostate cancer
aggressivness |
| Cancer antigen 72-4 |
|
| CDK family |
Measures activity of CDK family enzymes which potentially assesses
chemotherapy activity |
| CDKN24 |
|
| CDP/Cux |
Proteins abnormally expressed in breast cancers |
| CellSearch |
Circulating tumor cells |
| CeMines CellCorrect Lab |
Test detects molecular fingerprints of disease-related autoantibodies in blood |
| Chromosome 8q gain |
|
| c-Kit pharmDx |
Qualitatively identifies c-kit protein/ CD117 expression |
| Colorectal cancer test |
Detect surface layer exfoliated epithelial cells |
| Colorectal gene panel |
Evaluate likelihood of toxicity/response to 5FU, oxaliplatin, irinotecan |
| Colorectalert |
Sampling of rectal mucus/ clinical trial with EDRN initiated |
| Conversion Analysis |
Improved detection of genetic mutations associated with hereditary cancer |
| Cox-2 RNA |
|
| cPSA |
|
| CupPrint |
Gene expression |
| Cyfra 21-1 |
|
| Cytokeratin 20 |
|
| CytoVision |
Autosomal chromosomal analysis using FISH |
| des-gamma carboxyprothrombin |
|
| DNA methylation |
|
| DNA methylation |
Detects DNA methylation |
| EEF1A2 |
|
| EGFR |
|
| EGFR |
EGFR gene mutations |
| EPCA |
Blood test for EPCA |
| eTag |
Technology to improve analysis of HER factor family receptor |
| Genomic Test |
|
| GOS |
|
| GSTM1 |
|
| GSTP1 |
|
| Her-1, Her-2, Her-3, Her-4 |
|
| HLA-E |
|
| HP1alpha |
|
| HPV test |
HPV detection with Pap smear, identifies 51 types of HPV |
| HPV test |
|
| IGF-II |
|
| IMI breast cancer test |
Identifies cancer associated sugar in nipple aspirate fluid |
| Immunocyt/ uCyt |
Urine test for bladder cancer recurrence |
| Iressa test |
Determine response to Iressa |
| Key2 |
Detects changes in DNA copy number |
| K-ras |
|
| Leukemia Affymetrix Chip |
|
| Leukemia blood test |
|
| Lung cancer test |
Hybrid DNA and protein test for detection of lung cancer |
| Lung cancer test |
Detects 'smell prints' of numerous organic compounds in exhaled breath |
| LungAlert |
Sputum test for lung cancer |
| Lysophopholipids |
|
| M2-PK |
M2-PK protein in stool blood |
| MammaPrint |
70 gene expression signature |
| Matrix metalloproeinases |
|
| Melanoma inhibiting antigen |
|
| Melastatin |
|
| MESOMARK |
Blood test for soluble mesothelin related proteins |
| MGMT |
|
| Microsatelitte Analysis |
|
| MLH1 |
|
| MN protein |
|
| MSA |
|
| MSA analysis |
Urine test using microsatelitte DNA analysis |
| NAF test |
Analyzes 14 biomarkers found in breast ductal fluid |
| NMP179 |
Test for protein NMP179 |
| NMP22 |
|
| NMP35 |
Blood test for protein NMP35 |
| NMP48 |
Blood test for protein NMP48 |
| NMP66 |
Blood test for protein NMP66 |
| OncoVue breast cancer risk test |
Breast cancer risk test/mouthwash DNA test |
| Ovacheck |
Genomic blood test for detection of ovarian cancer |
| Ovarian cancer biomarker test |
Protein array for detecting ovarian cancer |
| Ovarian cancer test |
Blood test for 4 biomarkers |
| Ovarian cancer test |
Gene expression profile (115 gene array) for prognosis |
| Ovarian pap test |
|
| p16, p15, p14 deletions |
|
| p202 |
|
| p53 Affymetrix Chip |
|
| Prostate 63 |
|
| Prostate biomarkers |
|
| Prostate Cancer Blood Test |
|
| Protein Profile test |
|
| PSA testing |
Measures PSA levels |
| PSMA |
|
| PSP94 |
Blood test for PSP94 |
| PTEN tumor suppressor |
|
| PyloriProbe |
Quantifies fibrin degradation products in serum by a proprietary antibody |
| Recaf |
Potential biomarker for new cancer diagnostic tests |
| RhoC GTPase |
|
| S100 |
|
| SELDI-TOF-MS |
|
| SurePath |
Biomarkers associated with cervical cancer |
| Telomerase |
|
| TGF genes |
|
| TUO test |
Gene expression profiling of RNA for classification of tumors of unknown origin |
| uPM3 |
Urine test for PCA3 gene and PSA mRNA |
| Urinary plasminogen activator |
|
| Urine test for cervical cancer |
Urine test for high risk cervical cancer |
| VEGF |
Predict response to bevacizumab |
| WISP3 |
|
540 Gaither Road Rockville, MD 20850